EP1091808A1 - Device for determining an analyte in a liquid sample - Google Patents
Device for determining an analyte in a liquid sampleInfo
- Publication number
- EP1091808A1 EP1091808A1 EP99925064A EP99925064A EP1091808A1 EP 1091808 A1 EP1091808 A1 EP 1091808A1 EP 99925064 A EP99925064 A EP 99925064A EP 99925064 A EP99925064 A EP 99925064A EP 1091808 A1 EP1091808 A1 EP 1091808A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- capillary
- diffusion means
- zone
- capillary diffusion
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 38
- 239000012491 analyte Substances 0.000 title claims abstract description 31
- 238000009792 diffusion process Methods 0.000 claims abstract description 100
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 55
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 24
- 238000012546 transfer Methods 0.000 claims description 14
- 239000003550 marker Substances 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 6
- 238000011002 quantification Methods 0.000 claims description 5
- 238000013519 translation Methods 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 108050001427 Avidin/streptavidin Proteins 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- -1 haptens Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000013528 metallic particle Substances 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000002105 tongue Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0825—Test strips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/06—Valves, specific forms thereof
- B01L2400/0633—Valves, specific forms thereof with moving parts
- B01L2400/065—Valves, specific forms thereof with moving parts sliding valves
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/806—Fertility tests
Definitions
- the present invention relates to a device for determining an analyte present in a liquid sample.
- analyte means any entity, chemical, biochemical, or biological, which one wants to determine, that is to say identify or detect, and / or quantify, and / or measure.
- the present invention will be introduced, defined and described with reference to the determination of a biological entity, in particular a hormone, for example the hormone hcG making it possible to detect the state of pregnancy d 'a woman.
- a biological entity in particular a hormone, for example the hormone hcG making it possible to detect the state of pregnancy d 'a woman.
- liquid sample any sample in which the analyte sought is in solution or suspension, as it is directly applied or treated by the determination device which will be discussed below.
- This liquid sample may itself have been obtained from a sample or other sample containing the analyte, for example a body fluid, by physical, and / or chemical, and / or biological treatment. This means in particular that the dissolution or dispersion medium belonging to the liquid sample is not necessarily aqueous.
- a device for determining an analyte comprises: a) a gripping support, in the form of a housing, comprising at one end an opening for the passage of the second capillary diffusion means which will be discussed below, projecting outside the housing , and having an area for collecting a liquid sample; this box comprises, opposite the sensing member, a registered window with at least the downstream zone of the first capillary diffusion means which will be discussed below; b) said first capillary diffusion means, in a direction and a reference direction, integral and fixed in the gripping support, comprising a downstream area accessible to external observation, thanks to the aforementioned window recorded with said downstream area; c) a set of predetermined reagents for the detection and / or quantification of the analyte, comprising: a first reagent comprising a marker,
- the user removes the cap, then puts the liquid sample, for example a stream of urine, in direct contact with the collection zone of the second capillary diffusion means.
- Liquid sample migrates first, in the reference direction, towards the upstream zone of the first capillary diffusion means, in which, on the one hand it entrains the first reagent, and on the other hand the analyte binds to the latter, to form a conjugate.
- the abovementioned conjugate arrives by capillary entrainment in the downstream zone, in which the second reagent captures, and therefore immobilizes and concentrates, directly or indirectly, the first reagent, and therefore the conjugate.
- the existence and / or the amount captured of the conjugate can be read, and / or measured, directly or indirectly, for example with the naked eye in the case of a particulate marker, or by any means appropriate detection and / or measurement.
- document OA-97 26 083 describes a device for determining an analyte in a liquid sample, comprising: a) a gripping support, in the form of an elongated and flat case, open at its two ends, comprising on one face and at a first end a window; this housing serves as a slide for the liquid sample collection member which will be discussed below.
- this movable member consists of an elongated housing, obtained by definitive assembly of two complementary parts or shells, and incorporates, in continuity of capillary flow, on the one hand a first capillary diffusion means, entirely included in the housing, comprising a zone downstream accessible to external observation, and secondly a second capillary diffusion means, partly included in the housing, and comprising an end zone for collecting the liquid sample, protruding outside the housing; the casing also comprises, opposite a part allowing its manipulation, a window registered with the downstream zone of the first capillary diffusion means; the movable member is movable relative to the gripping support, from a starting position in which the zone for collecting the liquid sample from the movable member is capable of being brought into contact with the latter, and in which the window of the housing is masked by the gripping support, outside the gripping support, in a definitive retracted position, in which the
- the previously exposed device requires a removable means of protection of the collection area of the second capillary diffusion means, in the starting position of the movable member, in which the collection area protrudes outside the grip support.
- additional means provided, on one side on the movable member or housing, for example notches, and on the other side on the gripping support, for example tongues engaging in abutment in the aforementioned notches , the retracted position is final, as said above.
- the means of protection of the collection area is removed, to obtain the device ready for use, with its protruding collection area, - after collection of the liquid sample, the movable member is brought into the retracted position, -
- the result of the reaction on the first capillary diffusion means is observable through the two registered windows of the movable member and the gripping support respectively.
- the two devices described above have in common, on the one hand, the arrangement of the two capillary diffusion means, on a single element, namely the gripping support in the first case, and the movable member in the second case. , and on the other hand a structural continuity of capillary flow, that is to say permanent, from the liquid sample from the second capillary diffusion means to the first capillary diffusion means.
- a removable protection means must be provided for the collection area of the second capillary diffusion means in its starting position, that is to say protruding for the collection of the liquid sample.
- the subject of the present invention is a device as defined above making it possible to remove the additional means of removable protection of the zone for collecting the liquid sample, while isolating the latter from the outside of the device, as long as the latter is not used, that is to say implemented or armed for the taking of a liquid sample, then the reading of the result concerning the analyte.
- the device comprises a member for collecting the liquid sample, of which the second capillary diffusion means is integral, excluding the first capillary diffusion means .
- This pick-up member is mounted so as to be movable relative to the gripping support, for example in translation, between two extreme positions, namely: - one projecting with respect to the gripping support, in which on the one hand the area of collection of the liquid sample, belonging to the second capillary diffusion means, is capable of being brought into contact with the latter, outside the gripping support, and on the other hand an opposite transfer zone from the second capillary diffusion means to the collection zone is not in continuity of capillary flow, and therefore isolated with respect to the upstream zone of the first capillary diffusion means.
- the transfer zone of the second capillary diffusion means is, in a removable or temporary manner, in continuity of capillary flow, with the upstream zone of the first capillary diffusion means, and on the other hand the collection zone of the second capillary diffusion means is included in the gripping support.
- the device according to the invention is characterized by the dissociation of the two capillary diffusion means, and by the possibility of temporarily isolating these two means from screw of the capillary flow of the liquid sample.
- the device according to the invention is characterized, in addition to the set of predetermined reagents chosen for the detection and / or quantification of the analyte, by the fact that the first capillary diffusion means remains on the side of the gripping support, and that consequently the collection member is mainly assigned to the collection of the liquid sample.
- the two capillary diffusion means makes it possible to separate and sequence the sample itself, and the reaction or reactions required for the detection and / or quantification of the analyte, namely carrying out said sampling before the reaction (s).
- the displacement of the second capillary diffusion means, away from and at a distance from the first capillary diffusion means makes it possible, for a given length or size of the device, to have a greater length of collection of the liquid sample, in the projecting or projecting position of said device.
- a device according to the invention can be used with any set of predetermined reagents, depending on the analyte sought in the liquid sample, on the one hand, and the operating protocol used for the determination on the other hand.
- reagent any chemical, biochemical, or biological entity capable of binding with the analyte and / or another reagent.
- link is meant any strong bond, for example covalent, or weak, for example of the antigen / antibody or avidin / streptavidin type.
- the reagents considered according to the invention are biological entities, of the ligand or anti-ligand type, and this with respect to the analyte or another reagent, of the biological type.
- reagents such as antibodies, antigens, haptens, avidin / streptavidin, but also peptides, proteins, and polynucleotides are classified.
- the first and second reagents are respectively two specific, identical or different monoclonal antibodies, directed against the analyte.
- marker is meant any physical, chemical, biochemical or biological entity allowing directly or indirectly the determination of the first reagent, in particular when it is linked, directly or indirectly, to the analyte.
- a marker known per se, can be for example an enzyme, or also metallic particles, for example gold particles, obtained for example from colloidal gold.
- the first reagent is deposited on the second capillary diffusion means, in particular downstream of the collection zone of the capture member, or else the first reagent is deposited on the first capillary diffusion means, particularly downstream of the upstream area of said first means, but upstream of the downstream area accessible to external observation.
- the first and second reagents are then predetermined to bind respectively and specifically with the analyte, for example on two epitopic sites, identical or different from the analyte, when it consists of a biological molecule;
- the first reagent or the second reagent is predetermined 1 identical or similarly to the analyte, to bind with the other reagent, in competition with the analyte.
- an analyte constituted by a biological entity comprising two ligands, capable of binding respectively with the first reagent and a third reagent the latter is deposited in the free state, on a porous support, in l the second means of capillary diffusion or the first means capillary diffusion, at a location functionally upstream of the downstream zone of the first diffusion means.
- the second reagent is predetermined for the capture of the third reagent.
- another predetermined reagent to bind directly or indirectly with the first reagent is fixed in an adjacent area but downstream of the downstream area of the first means of diffusion, this adjacent area also being accessible to external observation.
- the first reagent comprises a particulate marker, for example gold particles, visible and / or measurable directly, when it is concentrated in the downstream region of the first diffusion means.
- a particulate marker for example gold particles, visible and / or measurable directly, when it is concentrated in the downstream region of the first diffusion means.
- FIG. 2 shows the device shown in Figure 1, in longitudinal and vertical section, in the retracted position of the capture member;
- - Figure 3 shows a perspective view, in the projecting position of the sensing member, a device according to a second embodiment of one invention;
- Figure 4 shows an exploded perspective view of the device shown in Figure 3, in the retracted position of the pickup member;
- a device according to the invention comprises:
- a gripping support 1 having the shape of a housing, comprising, at a distal end an opening for the passage of the capture member 4 described below towards the projecting position, and opposite this end a window ld registered with at least one downstream zone 2a of the first capillary diffusion means 2, described below;
- the first of the two capillary diffusion means having the form of a multi-layer strip, integral with the gripping support 1, and comprising the downstream zone 2a accessible to external observation; this first means is more particularly shown in exploded view in Figure 2, and will be described below in detail;
- a set of predetermined reagents for the detection and / or quantification of the analyte comprising at least:
- a first reagent 31 comprising a visible and / or measurable marker, this first reagent being disposed in the free state on the first diffusion means 2, in particular downstream of the upstream zone 2b, which will be discussed below ;
- FIG. 1) relative to said gripping support, in which the collection zone 41a is capable of being brought into contact with the liquid sample, outside of the gripping support, and in which the transfer zone (41b) is not in capillary flow continuity with, and therefore isolated from the upstream zone (2b) of the first capillary diffusion means (2), and the other retracted (cf. FIG. 2), in which the collection zone 41a is included in said gripping support, and in which the transfer zone (41b) of the second capillary diffusion means (41) is removably, that is to say temporary, in continuity of capillary flow with the upstream zone (2b) of the first capillary diffusion means (2); which explains why the capture member 4 and the gripping support 1 are elongated in the direction of translation.
- the upstream zone 2b of the first capillary diffusion means 2 is arranged to come, removably or temporarily, in continuity of capillary flow with the transfer zone 41b of the second capillary diffusion means 41, in the retracted position of the in order to be isolated with respect to the same capillary flow, with respect to the same transfer zone 41b, in the projecting position of the capture member 4.
- the first reagent 31 is deposited on the free state on the first diffusion means 2, as described above, in a zone 2a downstream of the upstream zone 2b; but of course, the first reagent can be deposited directly in the upstream zone 2b of the first capillary diffusion means 2, or even directly on the second capillary diffusion means 41.
- the gripping support 1 comprises a longitudinal slide 5, the shape of which is adapted to the path of movement of said member 4, and the latter comprises a member 6 of manual control crossing this slide.
- the stroke of the member 6 in the slide 5 determines the two extreme positions of the capture member 4, and as shown in Figure 2, has a length greater than the length of overlap of the transfer zone 41b of the second means 41 of capillary diffusion, and of the upstream zone (2b) of the first capillary diffusion means, in the retracted position of the device. As shown more particularly in FIG.
- the first capillary diffusion means 2 is obtained by assembling different sections or pieces, themselves fixed on a strip 28 of transparent plastic material, and in permanent continuity of capillary flow once assembled each other.
- the first capillary diffusion means 2 comprises: - a first section 21 of relatively large porosity, for example in cellulose, with a pore size of between 2 ⁇ m and 50 ⁇ m, arranged to come into capillary flow continuity with the transfer zone 41b of the second capillary diffusion means 41; it is this section which constitutes the upstream zone 2b of the first diffusion means 2;
- a section 24 of relatively low porosity for example made of nitrocellulose, with a porosity of between 1 ⁇ m and 30 ⁇ m, comprising, and the downstream zone 2a in which the second reagent 32 is fixed, and the adjacent zone in which is fixed the other reagent 33, these two zones being accessible to external observation through the registered window ld of the housing 1;
- the capture member 4 comprises a carriage 42 for supporting the second capillary diffusion means 41, included in the housing 1 or gripping support.
- the latter and the carriage 42 comprise means for guiding the displacement of said carriage, more particularly visible in FIG. 6, consisting of two slides 45 and 46 belonging to the housing 1, one upper and the other lower, and aligned, and in two corresponding ribs 43 and 44 belonging to the carriage 42, sliding in the slides 45 and 46 respectively.
- the second diffusion means 41 has the form of a relatively rigid rod, and the carriage 42 comprises a rear stop 42a relative to the direction of movement of said carriage, and a member 42b for holding the rod 41 in position, having the form of 'a ring.
- the housing 1 also incorporates a means 47 for actuating the carriage 42, with manual control 48.
- the actuation means 47 comprises a semi-rigid strip 49, shaped as a pin, of which a branch 49a has on its face outside a gripping member 48, the other branch of which has one end linked to the carriage 42.
- the housing 1 comprises a path 50 for guiding and pulling the strip, also in the form of a pin, and on the other hand a window lf adapted to the passage of the gripping member 48, the length of which is adapted to the travel of displacement of the capture member 4.
- this stroke has a much greater length to the overlap length of the transfer zone 41b of the second capillary diffusion means 41, and of the upstream zone 2b of the first capillary diffusion means 2, in the retracted position of the device. Consequently, by pushing the gripping member 48 towards the proximal end of the housing 1, as shown in FIG. 3, the strip 49 circulates in the guide path 50 and pushes the carriage 42 towards the projecting position of the member 2. In the opposite direction, the carriage 42 is moved to the retracted position of the capture member 4.
- the first capillary diffusion means 2 is clamped and held inside the housing between ribs 1a arranged parallel to the direction 60 of the capillary flow.
- the collecting member 4 is in the retracted position (cf. FIGS. 2 and 4 ), so that the box 1 is a closed entity, with the exception of the window ld; in the case of Figure 1, it is a flap 61, integral with the proximal end of the capture member 4, which closes the opening; and in the case of FIGS. 4 and 5, it is the end of the semi-rigid strip 49, opposite the carriage 42, which closes the opening on (cf. FIG. 5);
- the user brings the capture member 4 in the projecting position, in which a flow or liquid sample containing the analyte is brought into contact with the collection zone 41a;
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9808480 | 1998-06-30 | ||
FR9808480A FR2780317B1 (en) | 1998-06-30 | 1998-06-30 | DEVICE FOR DETERMINING AN ANALYTE IN A LIQUID SAMPLE |
PCT/FR1999/001380 WO2000000288A1 (en) | 1998-06-30 | 1999-06-10 | Device for determining an analyte in a liquid sample |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1091808A1 true EP1091808A1 (en) | 2001-04-18 |
EP1091808B1 EP1091808B1 (en) | 2003-07-09 |
Family
ID=9528186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99925064A Expired - Lifetime EP1091808B1 (en) | 1998-06-30 | 1999-06-10 | Device for determining an analyte in a liquid sample |
Country Status (16)
Country | Link |
---|---|
US (1) | US7459125B1 (en) |
EP (1) | EP1091808B1 (en) |
JP (1) | JP4505138B2 (en) |
CN (1) | CN1185050C (en) |
AT (1) | ATE244602T1 (en) |
AU (1) | AU4148399A (en) |
CA (1) | CA2335458A1 (en) |
DE (1) | DE69909484T2 (en) |
ES (1) | ES2204132T3 (en) |
FR (1) | FR2780317B1 (en) |
HU (1) | HUP0102735A3 (en) |
IL (1) | IL140165A (en) |
PL (1) | PL194051B1 (en) |
RS (1) | RS49670B (en) |
RU (1) | RU2205693C2 (en) |
WO (1) | WO2000000288A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013140089A1 (en) | 2012-03-19 | 2013-09-26 | Milovan Stankov | Device for determining at least one analyte capable of being contained in a liquid sample |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6773677B2 (en) * | 2002-01-09 | 2004-08-10 | Caliper Life Sciences, Inc. | Slide cassette for fluidic injection |
ES2525318T3 (en) * | 2002-10-11 | 2014-12-22 | Zbx Corporation | Diagnostic devices |
JP5630936B2 (en) * | 2004-02-09 | 2014-11-26 | ラピッド パトゲン スクリーニング インコーポレイテッドRapid Pathogen Screening Inc. | A method for detecting diseases at high speed by identifying targets in human body fluids |
FR2873208B1 (en) * | 2004-07-13 | 2007-12-07 | Vedalab Sa | DEVICE WITH A SAMPLING MEMBER FOR DETECTION OF AN ANALYTE IN A LIQUID SAMPLE |
CN101498717B (en) * | 2005-04-30 | 2013-08-28 | 美艾利尔瑞士公司 | Sample collecting device used for collecting solid or semi-solid sample |
FR2890173B1 (en) | 2005-08-23 | 2008-02-22 | Vedalab Sa | DEVICE FOR DETERMINING AN ANALYTE IN A LIQUID SAMPLE BY A SANDWICH TEST AND A COMPETITION TEST |
GB0811132D0 (en) | 2008-06-18 | 2008-07-23 | Secr Defence | Detection device |
JP5175395B2 (en) * | 2008-07-17 | 2013-04-03 | ザ プロクター アンド ギャンブル カンパニー | Method of using a flow cell apparatus to visualize additive deposition on a substrate |
AU2010330825B2 (en) * | 2009-12-18 | 2014-03-06 | Abbott Point Of Care, Inc. | Biologic fluid analysis cartridge |
BG110608A (en) * | 2010-03-01 | 2011-09-30 | Zentax Limited | Pregnancy tester |
US9744014B2 (en) * | 2010-10-15 | 2017-08-29 | Nestec S.A. | Oral engagement assemblies |
US9592507B2 (en) * | 2012-06-22 | 2017-03-14 | Abbott Point Of Care Inc. | Integrated cartridge housings for sample analysis |
WO2016176419A1 (en) * | 2015-04-30 | 2016-11-03 | Wellmetris, Llc | Sample collection device and method for urine and other fluids |
CN109922738A (en) * | 2016-10-28 | 2019-06-21 | 株式会社马尼金 | Image processing system for forecast analysis ovulation day |
WO2018079916A1 (en) * | 2016-10-28 | 2018-05-03 | 주식회사 바이탈스미스 | Image processing and analyzing system for ovulation detection and method for controlling same |
EP3619532B1 (en) | 2017-05-02 | 2022-07-13 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Plasma/serum separator device and methods using the same |
GB201816559D0 (en) * | 2018-10-10 | 2018-11-28 | Spd Swiss Prec Diagnostics Gmbh | Compact testing device |
EP4188600A1 (en) | 2020-07-29 | 2023-06-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Device for separation and/or preservation of a biofluid at a point-of-care, kit and method for identifying a disease |
CA3167468A1 (en) * | 2022-03-15 | 2023-09-15 | Zhejiang Orient Gene Biotech Co., Ltd. | Device for detecting an analyte in a liquid sample |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4774192A (en) * | 1987-01-28 | 1988-09-27 | Technimed Corporation | A dry reagent delivery system with membrane having porosity gradient |
DE560410T1 (en) | 1987-04-27 | 2001-12-20 | Unilever Nv | Test device for carrying out specific binding tests. |
US4981786A (en) * | 1987-09-04 | 1991-01-01 | Syntex (U.S.A.) Inc. | Multiple port assay device |
CA2158162A1 (en) * | 1993-03-17 | 1994-09-29 | Juan Pedro De Zoeten | Apparatus for the detection of a specifically reacting substance |
JP2665647B2 (en) * | 1993-07-08 | 1997-10-22 | 三共株式会社 | Portable diagnostic tool |
WO1995008761A1 (en) * | 1993-09-20 | 1995-03-30 | Polyfiltronics, Inc. | Analytical test formats and methods of conducting analytical tests |
IT1281738B1 (en) * | 1996-01-17 | 1998-02-27 | Boehringer Mannheim Italia | DEVICE FOR PERFORMING RAPID DIAGNOSTIC TESTS ON LIQUID SAMPLES |
US5980828A (en) * | 1996-05-28 | 1999-11-09 | Universal Healthwatch, Inc. | Combined sampling-assay device and holder |
AUPO071396A0 (en) * | 1996-06-28 | 1996-07-25 | Chandler, Howard Milne | Chromatographic assay or test device |
JP3753282B2 (en) * | 1996-07-29 | 2006-03-08 | 久光製薬株式会社 | Inspection device |
US6372514B1 (en) * | 1998-09-18 | 2002-04-16 | Syntron Bioresearch, Inc. | Even fluid front for liquid sample on test strip device |
US6140136A (en) * | 1998-09-18 | 2000-10-31 | Syntron Bioresearch, Inc. | Analytical test device and method of use |
US6150178A (en) * | 1999-03-24 | 2000-11-21 | Avitar, Inc. | Diagnostic testing device |
US6365417B1 (en) * | 2000-02-09 | 2002-04-02 | A-Fem Medical Corporation | Collection device for lateral flow chromatography |
-
1998
- 1998-06-30 FR FR9808480A patent/FR2780317B1/en not_active Expired - Fee Related
-
1999
- 1999-06-10 PL PL99345160A patent/PL194051B1/en unknown
- 1999-06-10 CN CNB998081264A patent/CN1185050C/en not_active Expired - Fee Related
- 1999-06-10 ES ES99925064T patent/ES2204132T3/en not_active Expired - Lifetime
- 1999-06-10 US US09/720,862 patent/US7459125B1/en not_active Expired - Fee Related
- 1999-06-10 CA CA002335458A patent/CA2335458A1/en not_active Abandoned
- 1999-06-10 JP JP2000556871A patent/JP4505138B2/en not_active Expired - Fee Related
- 1999-06-10 AT AT99925064T patent/ATE244602T1/en not_active IP Right Cessation
- 1999-06-10 AU AU41483/99A patent/AU4148399A/en not_active Abandoned
- 1999-06-10 IL IL14016599A patent/IL140165A/en not_active IP Right Cessation
- 1999-06-10 WO PCT/FR1999/001380 patent/WO2000000288A1/en active IP Right Grant
- 1999-06-10 HU HU0102735A patent/HUP0102735A3/en unknown
- 1999-06-10 RS YUP-833/00A patent/RS49670B/en unknown
- 1999-06-10 EP EP99925064A patent/EP1091808B1/en not_active Expired - Lifetime
- 1999-06-10 RU RU2001102607/04A patent/RU2205693C2/en not_active IP Right Cessation
- 1999-06-10 DE DE69909484T patent/DE69909484T2/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
See references of WO0000288A1 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013140089A1 (en) | 2012-03-19 | 2013-09-26 | Milovan Stankov | Device for determining at least one analyte capable of being contained in a liquid sample |
DE212013000068U1 (en) | 2012-03-19 | 2014-12-08 | Milovan Stankov | Apparatus for determining at least one analyte which may be contained in a liquid sample |
US9140700B2 (en) | 2012-03-19 | 2015-09-22 | Milovan Stankov | Device for determining at least one analyte capable of being contained in a liquid sample |
Also Published As
Publication number | Publication date |
---|---|
JP2002519650A (en) | 2002-07-02 |
HUP0102735A2 (en) | 2001-11-28 |
WO2000000288A1 (en) | 2000-01-06 |
IL140165A (en) | 2004-05-12 |
DE69909484D1 (en) | 2003-08-14 |
US7459125B1 (en) | 2008-12-02 |
PL194051B1 (en) | 2007-04-30 |
RU2205693C2 (en) | 2003-06-10 |
JP4505138B2 (en) | 2010-07-21 |
FR2780317A1 (en) | 1999-12-31 |
YU83300A (en) | 2003-04-30 |
AU4148399A (en) | 2000-01-17 |
DE69909484T2 (en) | 2004-04-15 |
HUP0102735A3 (en) | 2005-11-28 |
EP1091808B1 (en) | 2003-07-09 |
PL345160A1 (en) | 2001-12-03 |
ATE244602T1 (en) | 2003-07-15 |
ES2204132T3 (en) | 2004-04-16 |
CN1308562A (en) | 2001-08-15 |
CA2335458A1 (en) | 2000-01-06 |
IL140165A0 (en) | 2002-02-10 |
RS49670B (en) | 2007-09-21 |
FR2780317B1 (en) | 2000-08-11 |
CN1185050C (en) | 2005-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1091808B1 (en) | Device for determining an analyte in a liquid sample | |
JP2603611B2 (en) | Method and apparatus for optically identifying species parameters in liquid analytes | |
EP1917529B1 (en) | Analyte assaying by means of immunochromatography with lateral migration | |
EP3068515B1 (en) | Novel filter medium for obtaining plasma, and associated filtration device and method | |
JP4891317B2 (en) | Membrane array and analytical equipment | |
US20040019301A1 (en) | Integrated confirmation sample in a body fluid test device and method of using | |
US6372516B1 (en) | Lateral flow test device | |
EP0251946B1 (en) | Liquid sample analysing device | |
JP3727952B2 (en) | Automated immunoassay cassette | |
JP2001504573A (en) | Opposite component assay device using conductive barrier | |
US6440748B1 (en) | Process and device for carrying out fluorescence immunoassays | |
FR3107823A1 (en) | Urinalysis device and method | |
FR2997194A1 (en) | DEVICE FOR DETERMINING AT LEAST ONE ANALYTE LIKELY TO BE CONTAINED IN A LIQUID SAMPLE | |
FR3107824A1 (en) | Urinalysis device and method | |
JP2023544922A (en) | Rapid detection structure with integrated sampling and detection and its use | |
FR2828281A1 (en) | Device for analyzing a sample by means of a light beam, where a mirror with a discontinuity allows more light to shine through to the sample analyzer | |
WO2006016051A2 (en) | Device with removal member for detecting an analyte in a liquid sample | |
FR2918460A1 (en) | NEW DEVICE FOR OBTAINING THE RESULTS OF ABO SYSTEMS, RHESUS AND OTHER PHEROTYPES AND RARE SYSTEMS, RAI. | |
CH660633A5 (en) | Analysis apparatus for determining optical materials solution. | |
US20080311680A1 (en) | Method for detecting high antigen concentration and device therefor | |
JP3791640B2 (en) | Inspection device | |
WO2022207890A1 (en) | Device for rapid analysis of a biological sample, for example a salivary biological sample | |
JP3053494U (en) | Inspection tool | |
JP3314684B2 (en) | Analysis equipment | |
FR2875910A1 (en) | Immuno-chromatographic diagnostic test strip for detection of specific analyte in liquid, includes second bonding reagent combined with marker which is visible or can be measured |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010129 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20010129;LT PAYMENT 20010129;LV PAYMENT 20010129;MK PAYMENT 20010129;RO PAYMENT 20010129;SI PAYMENT 20010129 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
17Q | First examination report despatched |
Effective date: 20020612 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030709 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030709 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 69909484 Country of ref document: DE Date of ref document: 20030814 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: FRENCH |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20031009 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20031009 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20031104 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20031209 |
|
LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20030709 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2204132 Country of ref document: ES Kind code of ref document: T3 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040610 |
|
26N | No opposition filed |
Effective date: 20040414 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040630 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040630 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040630 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040630 |
|
BERE | Be: lapsed |
Owner name: *VEDALAB Effective date: 20040630 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FI Payment date: 20060519 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20060523 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20070616 Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1038523 Country of ref document: HK |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070610 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070611 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20090527 Year of fee payment: 11 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080610 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20090518 Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: V1 Effective date: 20110101 |
|
EUG | Se: european patent has lapsed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100611 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 18 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 19 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20180416 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20180412 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20180412 Year of fee payment: 20 Ref country code: ES Payment date: 20180725 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69909484 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20190609 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20190609 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20200724 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20190611 |